Alexander Garms-Rizzi, 23, was a former Royal Welsh Fusilier. He acted as “bait” to draw enemy fire away from his comrades during a frontline battle. Alexander was fatally wounded by a Russian drone ...

The cage was not a crib but a crate. The 3-month-old in question was not our child but our dog. We do have children, six of them. When Bruce and I got married a decade ago, our children — three ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

“This incident is truly shocking, and shows how quickly situations our frontline officers attend can escalate. There is absolutely no explanation as to why this incident needed to end the way it ...

It’s lovely and a great price." Another added: "Smells like heaven and I spray it all over my body. It’s really good and smells amazing" A third wrote: "This perfume has made me want to ...

Such may be the human condition. But as anyone who’s ever owned a dog will tell you, it’s not a problem—or a regret—that dogs seem to have. In their boundless joys and wild anxieties alike ...

Followed categories will be added to My News. The funds will support 24 frontline providers to run vital programs such as women’s safe houses, legal services, and community-led initiatives aimed ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

On a cold winter’s day in Ukraine’s Donetsk region, a group of soldiers, newly recruited, loaded their weapons and ran through snow-dusted trenches firing during drills designed to prepare ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato ... then they could also become frontline treatments for depression in general.

On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...